Henry Schein, Inc. (NASDAQ:HSIC) Shares Sold by Massmutual Trust Co. FSB ADV

Massmutual Trust Co. FSB ADV decreased its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 7.8% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 5,451 shares of the company’s stock after selling 464 shares during the quarter. Massmutual Trust Co. FSB ADV’s holdings in Henry Schein were worth $412,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently bought and sold shares of HSIC. Boston Partners boosted its stake in shares of Henry Schein by 144.1% during the 4th quarter. Boston Partners now owns 2,637,429 shares of the company’s stock valued at $199,393,000 after buying an additional 1,556,831 shares during the last quarter. Norges Bank bought a new position in Henry Schein during the 4th quarter valued at $111,715,000. Nuance Investments LLC acquired a new position in Henry Schein during the 4th quarter worth $103,446,000. Lazard Asset Management LLC increased its position in shares of Henry Schein by 1,303.3% in the 3rd quarter. Lazard Asset Management LLC now owns 1,247,334 shares of the company’s stock worth $92,614,000 after purchasing an additional 1,158,451 shares during the last quarter. Finally, Fiduciary Management Inc. WI increased its position in shares of Henry Schein by 17.1% in the 4th quarter. Fiduciary Management Inc. WI now owns 2,284,337 shares of the company’s stock worth $172,947,000 after purchasing an additional 333,855 shares during the last quarter. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Henry Schein Trading Down 2.5 %

Henry Schein stock opened at $66.55 on Friday. The firm has a 50-day moving average price of $70.52 and a two-hundred day moving average price of $73.11. Henry Schein, Inc. has a 52-week low of $60.01 and a 52-week high of $82.63. The firm has a market capitalization of $8.52 billion, a price-to-earnings ratio of 22.48, a PEG ratio of 1.68 and a beta of 0.90. The company has a quick ratio of 1.02, a current ratio of 1.75 and a debt-to-equity ratio of 0.47.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings data on Tuesday, May 7th. The company reported $1.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.01 by $0.09. Henry Schein had a return on equity of 13.51% and a net margin of 3.12%. The business had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.21 billion. During the same period in the previous year, the firm posted $1.21 earnings per share. The business’s revenue was up 3.7% on a year-over-year basis. Sell-side analysts expect that Henry Schein, Inc. will post 5.17 earnings per share for the current year.

Analyst Upgrades and Downgrades

HSIC has been the subject of a number of research reports. JPMorgan Chase & Co. lifted their price target on Henry Schein from $82.00 to $88.00 and gave the stock an “overweight” rating in a research note on Wednesday, March 6th. Barrington Research boosted their price target on Henry Schein from $90.00 to $92.00 and gave the company an “outperform” rating in a report on Wednesday, May 8th. UBS Group dropped their price target on Henry Schein from $82.00 to $80.00 and set a “neutral” rating on the stock in a research report on Wednesday, May 8th. Evercore ISI lifted their price objective on shares of Henry Schein from $79.00 to $83.00 and gave the stock an “in-line” rating in a report on Wednesday, February 28th. Finally, Piper Sandler increased their target price on shares of Henry Schein from $78.00 to $86.00 and gave the stock an “overweight” rating in a report on Monday, February 26th. One research analyst has rated the stock with a sell rating, six have given a hold rating and five have issued a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $81.73.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.